ADAMTS9 and lung adenocarcinoma: A previous research showed that ADAMTS9-AS2 is a prognostic biomarker correlated with immune infiltrates and predicted a poorer overall survival when it was low expressed in lung adenocarcinoma (Lin et al., 2021).